In Scotland, NHS Quality Improvement Scotland (NHS QIS) will consider any specific implications arising from the NICE guidance which will affect its use in Scotland.Until new guidance is issued to the NHS, not expected until October 2005, the existing guidance dating from 2001 on donepezil, galantamine and rivastigmine continues to apply.